NCT00310492View on ClinicalTrials.gov

Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

May 31, 2009

Study Completion Date

November 30, 2009

Conditions
Atopic Dermatitis
Interventions
BIOLOGICAL

subcutaneous immunotherapy

Updosing by 16 injections to 100,000 SQ-U

Trial Locations (1)

D-30449 Hannover

Medizinische Hochschule Hannover, Klinik für Dermatologie und Venerologie, Hanover

All Listed Sponsors
lead

ALK-Abelló A/S

INDUSTRY

NCT00310492 - Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic Dermatitis | Biotech Hunter | Biotech Hunter